celiprolol

celiprolol
Trade Name
Orphan Indication Ehlers-Danlos syndrome
USA Market Approval USA
USA Designation Date 2015-01-05 00:00:00
Sponsor Acer Therapeutics, Inc.;222 Third Street, Suite 2240;Cambridge, Massachusetts, 02142